• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 7
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue7

A Review Of Impact Of Covid On Hypertension

    Dr.Sumanth Kumar Dr. Senthil Nathan

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 5521-5527

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

In this review article, you can find a brief summary of the complicated relationship of age, hypertension, renin-angiotensin-aldosterone system (RAAS), infection with inflammation and serious acute coronavirus 2 syndrome (SARS-CoV2). In coorbid elderly patients, especially people with high blood pressure, diabetes, obesity and cardiovascular disease, Coronavirus Disease 2019 (COVID-19) is more common and more severe. The use of RAAS inhibitors in COVID-19 patients is concerned. There are questions. Some doctors have considered the need to avoid inhibition of RAAS in order to decrease the risk for SARS-CoV2 to enter lung cells following binding to angiotensin-converting enzyme 2 (ACE2) receptors. We have a different view of the need to proceed using RAAS inhibitors in COVID-19 patients1,2. Our article was based on elderly patients because of the marked mismatch of the depressed immune system and an intensified, inflaming, inflammatory response that makes the geriatric patient a good candidate for therapeutic strategies for inflammatory reaction modulation. COVID-19 is an infectious storm that begins and aggravates during the illness. Various therapeutic approaches, including antivirals, interferon, anti-interleukins, hydroxychloroquine, anti-inflammatory medications, immunoglobulins from returning patients and heparins, were tested during the COVID-19 Pandemic. Any of these therapies found not to be beneficial, or even to cause significant complications. On the basis of existing data, the path and outcome of COVID-19 might influence early regulation of inflammatory response by neprilysin inhibition and RAAS modulation
Keywords:
  • PDF (324 K)
  • XML
(2020). A Review Of Impact Of Covid On Hypertension. European Journal of Molecular & Clinical Medicine, 7(7), 5521-5527.
Dr.Sumanth Kumar; Dr. Senthil Nathan. "A Review Of Impact Of Covid On Hypertension". European Journal of Molecular & Clinical Medicine, 7, 7, 2020, 5521-5527.
(2020). 'A Review Of Impact Of Covid On Hypertension', European Journal of Molecular & Clinical Medicine, 7(7), pp. 5521-5527.
A Review Of Impact Of Covid On Hypertension. European Journal of Molecular & Clinical Medicine, 2020; 7(7): 5521-5527.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 60
  • PDF Download: 84
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus